The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings.

Biomed Pharmacother · 2020 · PMC8963534 · PMID 34321170

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

There was a favorable trend towards a reduction in the use of loop diuretics in the ARNI arm compared to the OMT arm (74.2 % vs. 86.4 %, NS) which, however, was not significant.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.